Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,624.70
(
-1.36%
)
US TECH 100
23,755.20
(
-1.56%
)
Dow Jones
46,225.15
(
-1.63%
)
Brent Oil
108.82
(
2.10%
)
Bitcoin
70,960.00
(
-0.37%
)
News Focus
News Focus

Replies to post #73786 on Biotech Values

Replies to #73786 on Biotech Values
icon url

genisi

03/01/09 1:18 AM

#73798 RE: DewDiligence #73786

CEPH - After getting an option to buy Ception Therapeutics for its humanized IL-5 Mab - reslizumab and acquiring rights to Lupuzor from ImmunPharma, CEPH makes another move, this time in the anti-TNF antibody arena.